Literature DB >> 26715292

Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer.

Kalaivani Murugan1, Vikas Ostwal2,3, Maria Deo Carvalho1, Anita D'souza1, Meera S Achrekar1, Shrinivasan Govindarajan1, Sudeep Gupta4.   

Abstract

INTRODUCTION: Capecitabine is an oral prodrug of 5-fluorouracil and is commonly used oral chemotherapeutic drugs for advanced gastric and colorectal cancer. However, hand-foot syndrome (HFS) has high incidence, and once developed, the symptoms significantly impair quality of life (QOL), leading to a reduction in the dosage or discontinuation of the treatment. Effective health education should be offered to patients to promote self-identification and management on how to recognize HFS and use self-management techniques at the very beginning of chemotherapy.
MATERIALS AND METHODS: The present study intended to evaluate the effectiveness of structured teaching program on knowledge related to self-identification and management of HFS among patients receiving chemotherapy for colon cancer at tertiary cancer care center. Participants who fulfilled the criteria were selected using non-probability purposive sampling. The sample selected were 40 participants (20 participants in experimental group and 20 participants in control group).
RESULTS: Among the group of 40 patients, 17 (85 %) participants in the experimental group and 17 (85 %) participants in the control group were receiving capecitabine and oxaliplatin (CAPOX) chemotherapy treatment protocol. Five (25 %) participants in the experimental group and ten (50 %) participants in the control group were receiving drug capecitabine at a dose of 2500 mg. The mean knowledge (knowledge related to self-identification and management of HFS) pretest score was 6.75 and mean knowledge posttest score was 10.25 in the experimental group which was statistically significant (p = 0.000) (p < 0.05). The mean knowledge pretest score of participants was 6.45 and mean knowledge posttest score of participants was 6.75 in the control group which was not statistically significant (p = 0.67) (p > 0.05).
CONCLUSION: The study showed a statistically significant improvement in knowledge scores of participants that occurred due to intervention of structured teaching program. This can be used to assess reduction in incidence of HFS in the future.

Entities:  

Keywords:  Capecitabine; HFS; Knowledge; Structured teaching module

Mesh:

Substances:

Year:  2015        PMID: 26715292     DOI: 10.1007/s00520-015-3061-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  12 in total

1.  Structured teaching programme for women undergoing abdominal hysterectomy.

Authors:  Deny Anie Mathew
Journal:  Nurs J India       Date:  2011-06

2.  Effectiveness of planned pre-operative teaching on self-care activities for patients undergoing cardiac surgery.

Authors:  Nirmal Kaur; Prem Verma; Rana Sandip Singh
Journal:  Nurs J India       Date:  2007-06

3.  Capecitabine induced Hand-Foot Syndrome: Report of two cases.

Authors:  Sunil Sanghi; R S Grewal; Biju Vasudevan; A Nagure
Journal:  Med J Armed Forces India       Date:  2012-08-14

Review 4.  Capecitabine-induced hand-foot syndrome complicated by pseudomonal superinfection resulting in bacterial sepsis and death: case report and review of the literature.

Authors:  Fridolin J Hoesly; Sarah G Baker; Nilanthi D Gunawardane; Jonathan A Cotliar
Journal:  Arch Dermatol       Date:  2011-12

Review 5.  Capecitabine and hand-foot syndrome.

Authors:  Muhammad Wasif Saif
Journal:  Expert Opin Drug Saf       Date:  2010-12-22       Impact factor: 4.250

6.  [Assessment of hand-foot syndrome in cancer patients treated with capecitabine-containing chemotherapy].

Authors:  Kouhei Yamagiwa; Tadashi Shigematsu; Keiko Takeda; Masahiro Shirai; Keiko Amemori; Kazumi Sunda; Chikayo Koike; Toshimi Yamada
Journal:  Gan To Kagaku Ryoho       Date:  2013-12

Review 7.  Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.

Authors:  Joan D Webster-Gandy; Chris How; Karen Harrold
Journal:  Eur J Oncol Nurs       Date:  2007-03-09       Impact factor: 2.398

8.  Capecitabine as adjuvant treatment for stage III colon cancer.

Authors:  Chris Twelves; Alfred Wong; Marek P Nowacki; Markus Abt; Howard Burris; Alfredo Carrato; Jim Cassidy; Andrés Cervantes; Jan Fagerberg; Vassilis Georgoulias; Fares Husseini; Duncan Jodrell; Piotr Koralewski; Hendrik Kröning; Jean Maroun; Norbert Marschner; Joseph McKendrick; Marek Pawlicki; Riccardo Rosso; Johannes Schüller; Jean-François Seitz; Borut Stabuc; Jerzy Tujakowski; Guy Van Hazel; Jerzy Zaluski; Werner Scheithauer
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

9.  Palmar-plantar hyperpigmentation with capecitabine in adjuvant colon cancer.

Authors:  Michael M Vickers; Jacob C Easaw
Journal:  J Gastrointest Cancer       Date:  2009-05-14

10.  Incidence and self-management of hand-foot syndrome in patients with colorectal cancer.

Authors:  YiYuan Zhao; Yue Ding; YuHan Lu; Jie Zhang; Jin Gu; Ming Li
Journal:  Clin J Oncol Nurs       Date:  2013-08-01       Impact factor: 1.027

View more
  6 in total

1.  Effect of a Structured Teaching Module Including Intensive Prophylactic Measures on Reducing the Incidence of Capecitabine-Induced Hand-Foot Syndrome: Results of a Prospective Randomized Phase III Study.

Authors:  Vikas Ostwal; Akhil Kapoor; Sarika Mandavkar; Neeta Chavan; Tarachand Gupta; Jimmy Mirani; Avanish Saklani; Ashwin Desouza; Kalaivani Murugan; Chaitali Nashikkar; Sudeep Gupta; Anant Ramaswamy
Journal:  Oncologist       Date:  2020-09-04

2.  Topical henna and curcumin (Alpha®) ointment efficacy for prevention of capecitabine induced hand-foot syndrome: A randomized, triple-blinded, placebo-controlled clinical.

Authors:  Sepideh Elyasi; Sara Rasta; Ali Taghizadeh-Kermani; Sare Hosseini
Journal:  Daru       Date:  2022-03-23       Impact factor: 4.088

3.  New insights into frequency and contents of fear of cancer progression/recurrence (FOP/FCR) in outpatients with colorectal carcinoma (CRC) receiving oral capecitabine: a pilot study at a comprehensive cancer center.

Authors:  Jochen Hefner; Sara Berberich; Elena Lanvers; Maria Sanning; Ann-Kathrin Steimer; Volker Kunzmann
Journal:  Patient Prefer Adherence       Date:  2017-11-14       Impact factor: 2.711

4.  Management of cytotoxic chemotherapy-induced hand-foot syndrome.

Authors:  Johannes J M Kwakman; Yannick S Elshot; Cornelis J A Punt; Miriam Koopman
Journal:  Oncol Rev       Date:  2020-05-13

5.  An Observational Study of Team Management Approach for CapeOX Therapy in Patients with Advanced and Recurrent Colorectal Cancer: SMILE Study (The Study of Metastatic colorectal cancer to investigate the Impact of Learning Effect).

Authors:  Hiroshi Matsuoka; Yutaka Ogata; Michio Nakamura; Yoshihisa Shibata; Yoshinori Munemoto; Hiroyuki Bando; Koji Nishijima; Hiroyuki Okuda; Itsuro Terada; Takeru Shiroiwa; Junji Kishimoto; Kotaro Maeda
Journal:  J Anus Rectum Colon       Date:  2020-04-28

6.  Side Effects, Self-Management Activities, and Adherence to Oral Anticancer Agents.

Authors:  Yun Jiang; Karen E Wickersham; Xingyu Zhang; Debra L Barton; Karen B Farris; John C Krauss; Marcelline R Harris
Journal:  Patient Prefer Adherence       Date:  2019-12-31       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.